tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARWR full AI Analyst Report?

Arrowhead Pharmaceuticals (ARWR) Ratios

1,673 Followers

Arrowhead Pharmaceuticals Ratios

ARWR's free cash flow for Q1 2026 was $0.98. For the 2026 fiscal year, ARWR's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 3.38 4.86 6.74 3.98 2.92
Quick Ratio
 3.38 4.86 6.74 3.98 3.07
Cash Ratio
 0.58 1.16 1.00 1.05 0.78
Solvency Ratio
 0.22 0.03 -0.61 -0.40 -0.61
Operating Cash Flow Ratio
 0.98 0.92 -4.49 -1.46 -0.98
Short-Term Operating Cash Flow Coverage
 8.48 4.49 -72.98 -14.57 -49.04
Net Current Asset Value
$ 132.91M$ 68.76M$ -253.27M$ -58.87M$ 131.70M
Leverage Ratios
Debt-to-Assets Ratio
 0.19 0.26 0.75 0.50 0.12
Debt-to-Equity Ratio
 0.55 0.79 4.59 1.41 0.20
Debt-to-Capital Ratio
 0.35 0.44 0.82 0.59 0.17
Long-Term Debt-to-Capital Ratio
 0.22 0.32 0.80 0.50 0.00
Financial Leverage Ratio
 2.82 2.97 6.15 2.82 1.74
Debt Service Coverage Ratio
 2.65 1.11 -14.44 -6.18 -59.82
Interest Coverage Ratio
 3.33 1.10 -18.58 -11.19 0.00
Debt to Market Cap
 0.02 0.06 0.32 0.10 <0.01
Interest Debt Per Share
 2.88 3.41 7.38 3.74 0.77
Net Debt to EBITDA
 0.30 0.85 -1.33 -1.55 0.16
Profitability Margins
Gross Profit Margin
97.70%97.12%100.00%100.00%100.00%
EBIT Margin
31.64%16.99%-16336.47%-78.16%-71.01%
EBITDA Margin
33.93%19.87%-15812.81%-72.97%-66.72%
Operating Profit Margin
27.55%11.86%-16927.06%-85.16%-73.39%
Pretax Profit Margin
23.68%6.21%-17247.54%-85.78%-71.01%
Net Profit Margin
18.54%-0.20%-16882.37%-85.27%-72.39%
Continuous Operations Profit Margin
21.41%3.63%-17169.61%-86.93%-72.56%
Net Income Per EBT
78.30%-3.16%97.88%99.41%101.94%
EBT Per EBIT
85.95%52.40%101.89%100.73%96.75%
Return on Assets (ROA)
12.61%-0.12%-52.60%-26.81%-25.44%
Return on Equity (ROE)
36.12%-0.35%-323.27%-75.65%-44.18%
Return on Capital Employed (ROCE)
23.92%8.27%-57.98%-31.06%-32.27%
Return on Invested Capital (ROIC)
20.84%4.65%-57.37%-30.57%-32.11%
Return on Tangible Assets
12.66%-0.12%-52.99%-27.18%-25.89%
Earnings Yield
1.95%-0.04%-25.84%-7.12%-5.05%
Efficiency Ratios
Receivables Turnover
 4.98 121.55 0.00 0.00 172.50
Payables Turnover
 0.76 1.35 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 2.59 1.95 <0.01 0.72 1.44
Asset Turnover
 0.68 0.60 <0.01 0.31 0.35
Working Capital Turnover Ratio
 1.38 1.23 <0.01 0.83 0.96
Cash Conversion Cycle
 -406.06 -266.60 0.00 0.00 2.12
Days of Sales Outstanding
 73.23 3.00 0.00 0.00 2.12
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 479.29 269.60 0.00 0.00 0.00
Operating Cycle
 73.23 3.00 0.00 0.00 2.12
Cash Flow Ratios
Operating Cash Flow Per Share
 2.42 1.34 -3.86 -1.43 -1.29
Free Cash Flow Per Share
 2.30 1.17 -5.05 -3.08 -1.79
CapEx Per Share
 0.12 0.17 1.18 1.65 0.50
Free Cash Flow to Operating Cash Flow
 0.95 0.87 1.31 2.15 1.39
Dividend Paid and CapEx Coverage Ratio
 19.62 7.92 -3.27 -0.87 -2.58
Capital Expenditure Coverage Ratio
 19.62 7.92 -3.27 -0.87 -2.58
Operating Cash Flow Coverage Ratio
 1.08 0.49 -0.54 -0.40 -1.67
Operating Cash Flow to Sales Ratio
 0.31 0.22 -130.34 -0.64 -0.56
Free Cash Flow Yield
3.11%3.40%-26.05%-11.47%-5.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 51.18 -2.83K -3.87 -14.05 -19.79
Price-to-Sales (P/S) Ratio
 9.49 5.56 653.40 11.98 14.33
Price-to-Book (P/B) Ratio
 18.21 9.90 12.51 10.63 8.74
Price-to-Free Cash Flow (P/FCF) Ratio
 32.14 29.41 -3.84 -8.72 -18.44
Price-to-Operating Cash Flow Ratio
 30.51 25.69 -5.01 -18.74 -25.60
Price-to-Earnings Growth (PEG) Ratio
 <0.01 28.35 -0.02 -0.98 -0.87
Price-to-Fair Value
 18.21 9.90 12.51 10.63 8.74
Enterprise Value Multiple
 28.26 28.84 -5.47 -17.97 -21.31
Enterprise Value
 10.46B 4.75B 3.07B 3.16B 3.46B
EV to EBITDA
 28.26 28.84 -5.47 -17.97 -21.31
EV to Sales
 9.59 5.73 864.39 13.11 14.22
EV to Free Cash Flow
 32.49 30.30 -5.08 -9.55 -18.30
EV to Operating Cash Flow
 30.83 26.47 -6.63 -20.51 -25.40
Tangible Book Value Per Share
 3.97 3.71 1.52 2.58 3.85
Shareholders’ Equity Per Share
 4.06 3.48 1.55 2.53 3.78
Tax and Other Ratios
Effective Tax Rate
 0.10 0.42 <0.01 -0.01 -0.02
Revenue Per Share
 7.79 6.20 0.03 2.24 2.31
Net Income Per Share
 1.44 -0.01 -5.00 -1.91 -1.67
Tax Burden
 0.78 -0.03 0.98 0.99 1.02
Interest Burden
 0.75 0.37 1.06 1.10 1.00
Research & Development to Revenue
 0.57 0.71 142.46 1.47 1.22
SG&A to Revenue
 0.13 0.15 27.27 0.38 0.51
Stock-Based Compensation to Revenue
 0.06 0.08 20.83 0.32 0.50
Income Quality
 1.45 5.96 0.76 0.74 0.77
Currency in USD